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Abstract
The goal of this editorial is to summarize the 2019 International Conference on Intelligent Biology and Medicine
(ICIBM 2019) conference that took place on June 9–11, 2019 in The Ohio State University, Columbus, OH, and to
provide an introductory summary of the seven articles presented in this supplement issue. ICIBM 2019 hosted four
keynote speakers, four eminent scholar speakers, five tutorials and workshops, twelve concurrent sessions and a
poster session, totaling 23 posters, spanning state-of-the-art developments in bioinformatics, genomics, next-
generation sequencing (NGS) analysis, scientific databases, cancer and medical genomics, and computational drug
discovery. A total of 105 original manuscripts were submitted to ICIBM 2019, and after careful review, seven were
selected for this supplement issue. These articles cover methods and applications for functional annotations of
miRNA targeting, clonal evolution of bacterial cells, gene co-expression networks that describe a given phenotype,
functional binding site analysis of RNA-binding proteins, normalization of genome architecture mapping data,
sample predictions based on multiple NGS data types, and prediction of an individual’s genetic admixture given
exonic single nucleotide polymorphisms data.
Introduction
The 2019 International Conference on The Intelligent
Biology and Medicine (ICIBM 2019), the official confer-
ence of the International Association for Intelligent Biol-
ogy and Medicine (IAIBM), was co-hosted by IAIBM and
the Department of Biomedical Informatics at The Ohio
State University. The conference was held in June 9–11,
2019 in Columbus, OH. The goal of the conference was to
foster inter-disciplinary research and discussions, educa-
tional opportunities, and collaborative efforts among the
fields of bioinformatics, systems biology, and intelligent
computing, and data science, which are continuing to
evolve at a rapid pace and have a strong impact in scien-
tific research and medical innovations.
Building upon the successes of previous years’ confer-
ences [1–6], we brought together 79 researchers and 84
trainees from a wide array of national and international
institutions. The backgrounds and expertise of these 163
conference participants were highly diverse, and included,
among others, bioinformatics, medicine, machine learning,
artificial intelligence, metabolomics, genomics, and other
omics, drug repurposing, database development, and
systems biology and network analysis. ICIBM 2019 thus
provided a balanced mix of trainees and world-renown
scientists, scientific expertise, oral and poster presenta-
tions, workshops, tutorials, and plenty of built-in breaks
for invaluable discussions and networking.
A total of 105 original manuscripts and 36 abstracts
were submitted. Topics covered by submissions included
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next-generation sequencing, single cell analyses, deep
learning, metabolomics, genomics, and other omics
research, systems biology, medical applications and
translational research involving high-throughput data,
computational methods and novel applications of com-
putational tools, and others. Realizing the prominent
impact of data science and high-throughput data in in-
telligent biology and medicine, ICIBM spanned current
topics, with the intention of bridging topics together and
fostering a cross-disciplinary environment.
Realizing that the future is in the hands of trainees,
ICIBM 2019 is proud to promote participation of
trainees at the conference. To this end, ICIBM 2019 re-
ceived support from the National Science Foundation,
through which 20 national and international trainees
from various background received travel awards. Awardees
were selected by an Award Committee which carefully
reviewed applications and balanced the quality of the
research proposed, the financial need, and the diversity of
the applicants during the selection process.
In this editorial, we provide a summary of the scientific
program of ICIBM 2019, and of the 7 research articles se-
lected for the ICIBM 2019 BMC Genomics Supplement
Issue.
ICIBM 2019 scientific program
The ICIBM 2019 scientific program included 4 inter-
nationally renowned keynote speakers, 4 eminent scholar
speakers, and 5 tutorials and workshops. In addition, we
hosted 12 concurrent scientific sessions and a poster
session with 23 accepted abstracts. ICIBM 2019 was held
over 3 days, and provided multiple breaks in between
sessions to foster discussions and networking.
Keynote speakers
ICIBM 2019 provided an exciting line-up of four world-
renowned researchers that showcased their work and
perspectives in advances in genome technologies, scien-
tific databases for metabolic modeling and omics data
analysis, pediatric precision cancer medicine, and human
signaling networks. Speakers included 1) Dr. Jeremy
Edwards, Professor in the Department of Chemistry &
Chemical Biology, Albuquerque, NM, USA, 2) Dr. Peter
Karp, Director, Bioinformatics Research Group, Artificial
Intelligence Center, SRI, 3) Dr. Elaine Mardis, Co-
executive Director of the Institute for Genomic Medicine
at Nationwide Children’s Hospital and the Nationwide
Foundation Endowed Chair of Genomic Medicine, Profes-
sor of Pediatrics at The Ohio State University College of
Medicine, and the President of The American Association
for Cancer Research (AACR) 4) Dr. T.M. Murali, Depart-
ment of Computer Science, Virginia Tech, Blacksburg VA.
“Technologies for Human Genome and Transcriptome
Sequencing” by Dr. Jeremy Edwards.
Dr. Edwards highlighted exciting technological ad-
vances that aim to sequence and assemble complex and
repetitive areas of the genome. These technologies address
limitations in current sequencing technologies, including
limited read length and the difficulty in identifying disease-
related haplotypes. His methods and tools are applied in
disease-association studies where whole genome sequen-
cing can be used to resolve haplotypes, and to more fully
grasp mechanisms of the human genome and complex
disease phenotypes.
“BioCyc Tools for Metabolic Modeling and Omics Data
Analysis” by Dr. Peter Karp.
Dr. Karp showcased recent developments in BioCyc,
an extensive scientific database and web portal compris-
ing 14,500 microbial genomes and 2700 experimentally
elucidated metabolic pathways from multi-organisms
[7]. These developments include functionalities of the
BioCyc Pathway Tools software, including the ability to
develop an organism-specific quantitative metabolic model
by computing a metabolic reconstruction of a defined
organism from sequenced genomes. To address the issue of
gaps in metabolic networks that are due to incomplete gen-
ome annotations, Dr. Karp presented a novel algorithm,
for taxonomic, to fill these gaps. Further, Dr. Karp pre-
sented the newly developed Omics Dashboard, which sup-
ports integrative analysis and visualization of
transcriptomic and metabolomic data.
“A System for Pediatric Precision Cancer Medicine” by
Dr. Elaine Mardis.
Dr. Mardis highlighted her precision medicine efforts
in characterizing genomic events, such as somatic alter-
ations and germline predispositions, that lead to pediatric
cancer development and progression. These ongoing ef-
forts include the development and real-time application of
DNA and RNA next-generation-sequencing (NGS)-based
analysis that are used in the clinic to characterize an indi-
vidual patient’s tumor type. This characterization is in
turn utilized to make more accurate diagnosis, leading to
personalized therapeutic decisions. Dr. Mardis highlighted
specific case studies where this NGS-based strategy to pre-
cision medicine was successfully applied.
“Pathways on Demand: Automated Reconstruction of
Human Signaling Networks” by Dr. T.M. Murali.
Dr. Murali presented his exciting work in systems biol-
ogy, where he aims to make use of existing signaling path-
way annotations to identify novel molecular interactions
that could be included in pathways. To this end, he intro-
duced three novel approaches, PathLinker [8], RegLinker
[9], and XTalk [10], that can identify the shortest paths
from receptors to transcription factors in a pathway, find
the controls for non-pathway interaction in computed
paths, and that produces precise networks of interactions
and mechanisms, respectively. His work exemplifies that
utility of automated analyses for prioritizing proteins and
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their interactions for further studies, and the ability of his
methods to uncover novel pathways in Wnt/β-catenin sig-
naling, which have been validated experimentally.
Eminent scholar speakers
“ToppCell: A workbench for the analysis, modeling and
prediction of the molecular basis of development and
function of cells and tissues based on single cell atlas
datasets” by Dr. Bruce Aronow.
Dr. Aronow described novel approaches for modeling
tissues as ensembles of cell types and states, to improve
the ability to interpret and extract relevant biological in-
formation from single cell atlas data. To accomplish this,
Dr. Aronow developed ToppCell, an open access web
database that supports exploration and analysis of single
cell genomic datasets. ToppCell also provides access to
gene signatures from various cells, tissues, and perturba-
tions as computable modules that can be compared
against a user dataset, thereby revealing mechanisms of
cell subtype functions. Modules are then modeled as
networks of genes and pathways that explain functions
shared by the top overexpressed genes. An adapted ver-
sion of ToppCluster [11] was then utilized to identify
intercellular networks, that has been shown to uncover
underlying differentiation processes and new subtypes of
cells in the brain and lung.
“Identifying biologically relevant modules in metabolo-
mics and lipidomics data with Differential Network-based
Enrichment Analysis (DNEA)” by Dr. Alla Karnovsky.
Dr. Karnovsky highlighted the Differential Network
Enrichment Analysis (DNEA) method [12]. DNEA is a
novel data-driven approach to constructing metabolic
networks from metabolomic and lipidomic data. These
networks in turn generate relevant biological insights.
DNEA builds partial correlation networks using joint
structural sparsity estimation, identifies highly connected
subnetworks using consensus clustering, and finally uses
differentially enriched subnetworks using Network-based
Gene Set Analysis. DNEA has been successfully applied
to public data, leading to the identification of biologically
relevant interacting biomolecules that are associated
with disease phenotypes.
“The impact of sequence variants on protein function”
by Dr. Jeffrey Parvin.
Dr. Parvin presented a novel high-throughput functional
analysis assay to characterize the functional impact of gen-
omic missense substitutions. The multiplexed assay was
applied to study the effect of these variants in the tumor
suppressor gene BRCA1 on DNA repair function [13].
The approach yielded functional data on > 1000 missense
substitutions in the amino terminus of BRCA1, which
were largely consistent with the function measured by in-
dependent assays. The utility of this assay provides the
ability to characterize the potential function of a large
number of BRCA1 variants, including those for which the
function is still unknown.
“Prediction, searching and clustering of tandem mass
spectra of peptides” by Dr. Haixu Tang.
Dr. Tang presented his recently developed computa-
tional tools that aim to cluster, search, and predict peptide
tandem mass spectra to mine large-scale MS/MS datasets
[14]. These tools use machine learning to make in silico
predictions of peptide MS/MS spectra directly from
peptide sequences, without any prior knowledge about
fragmentation rules. A variety of techniques, including
run-length encoding to compress MS/MS spectra and
locality sensitive hashing to index spectra, were applied to
scale the algorithms and speed up the predictions. These
algorithms have been shown to efficiently augment inter-
pretation of high-throughput proteomic data.
Tutorials and workshops
ICIBM 2019 hosted five tutorials and workshops that
covered the state-of-the-art techniques involving data sci-
ence applications to cancer research, machine learning,
usage of BioCyc web portal, and epigenetics data analysis.
“Machine learning demystified” by Dr. Yan Guo,
University of New Mexico.
In this workshop, Dr. Guo introduced concepts of
machine learning that are applied in biomedical research,
including high throughput genomic data. Methods cov-
ered included hierarchical clustering, principal compo-
nents analysis, decision trees, random forests, and finally
neural networks.
“Data driven cancer research: data science research
and applications” by Drs. Wenjin Zheng, The University
of Texas Health Science Center at Houston, Yidong
Chen, The University of Texas Health Science Center at
Houston, and Yufei Huang, The University of Texas
Health Science Center at San Antonio.
This workshop highlighted various aspects of data-
driven models used in cancer research, including the
analysis of a wide range of data sources from electronic
records to genomic data. The workshops opened with a
discussion on building an appropriate infrastructure to
support such research. Live research projects used to
explain different models and their use, such as clinical
decision support. Three data-driven projects were also
described, to exemplify how genomic data and artificial
intelligence can be harnessed to discover novel cancer
therapies, to predict drug combination synergies, and to
predict N6-methyladenosine disease associations.
“Data driven cancer research: tutorial on deep learning
for cancer genomics” by Drs. Wenjin Zheng, The
University of Texas Health Science Center at Houston,
Yidong Chen, The University of Texas Health Science
Center at Houston, and Yufei Huang, The University
of Texas Health Science Center at San Antonio.
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The goal of this tutorial was to introduce the audience
to the basics of deep learning, and applications of deep
learning to genomics data, with a particular emphasis on
cancer genomics research. This tutorial introduced the
basics of deep learning and their applications, a compre-
hensive survey on how to generate deep learning models
to analyze “omics” datasets and predict drug responses.
“BioCyc microbial genomes web portal” by Dr. Peter
Karp, SRI International.
This tutorial showcased BioCyc, a user-friendly genome
informatics portal comprising 14,700 microbial genomes.
Biocyc provides information from multiple microbial data-
bases, literature curated information, and a large suite of
bioinformatics tools. The first part of the tutorial intro-
duced BioCyc and how to interact with the web portal.
The second part explained the workflow for analyzing the
integration of transcriptomic and metabolomic data.
Finally, Dr. Karp provided a tutorial on sing SmartTables
to store, share, and analyze lists of genes and metabolites,
and to perform comparative analysis across multiple
organisms.
“Machine learning for epigenomics data integration
and gene regulation” by Dr. Jianrong Wang, Michigan
State University.
This workshop introduced software tools implemented
a suite of machine learning algorithms. The software
provides a means of integrating high-dimensional epige-
nomics data with transcriptomic and genomic informa-
tion. Dr. Wang also introduced the mathematical basis
underlying these algorithms, discussed software per-
formance, and demonstrating it by using examples of
biological applications. Four types of prediction prob-
lems were covered by these algorithms: 1) prediction
of regulatory element families, 2) chromatin domain
segmentation, 3) identification of targeted genes regu-
lated by regulatory elements, and 4) prioritizing gen-
etic variants that may cause regulation of epigenetics
and genes.
Scientific sessions
Twelve concurrent sessions were held at ICIBM 2019,
and included talks delivered by faculty, postdoctoral
fellow, and PhD students. Sessions included speakers
that were peer-review selected from top ranked manu-
scripts, spanning a wide array of expertise including
bioinformatics, genomics, next-generation sequencing
analysis, scientific databases, cancer and medical genom-
ics, and computational drug discovery. We also included
2 sessions for short oral presentation to provide oppor-
tunities for high quality abstracts to present orally.
Finally, one oral session was included to highlight prom-
inent research endeavors from our international com-
munity. The twelve sessions were:
1. Next-generation Sequencing and Tools
2. General Genomics
3. Bioinformatics I
4. Next-generation Sequencing and Tools II
5. Bioinformatics II
6. Cancer Genomics I
7. Cancer Genomics II
8. Scientific Databases
9. Computational Drug Discovery
10. International Highlight Talks
11. Short Talk Session I
12. Short Talk Session II
Poster session
The poster session comprised 23 posters delivered by
trainees and faculty. Posters represented various work
highlighting bioinformatics methods and workflows
leveraging molecular or clinical data, that were devel-
oped or applied to cancer biology, immunotherapy and
chemotherapy, drug-drug interaction analysis, predictive
modeling of prognosis or diagnosis, neurobiology, single
cell analyses, interpretation and analysis of individual
and integrated omics data, signaling kinetics, gene regu-
lation of model systems (e.g. Drosophila), analysis of
pseudogenes, and drug repurposing. Session details are
available on the conference website (https://icibm2019.
org/) and in the printed program book which was pro-
vided to conference participants.
Summaries of manuscripts in this issue
In this supplement, 7 research manuscripts were selected
(out of 105 total submitted), through a review process
that included at least three reviewers, followed by revi-
sions as needed before final review and acceptance.
Li et al. [15] report a comprehensive database of po-
tential microRNA target single nucleotide variants
(SNVs) sites in the 3’UTR of mRNAs and their associ-
ated functional annotations. The goal of compiling this
resource is to guide identification of putative SNVs that
affect miRNA targeting, and prioritization of these sites
based on their functional impact. The database is freely
available at: https://sites.google.com/site/jpopgen/
dbNSFP.
Ismail et al. [16] present a maximum likelihood
method for reconstructing the clonal evolution of bac-
terial cells using time course pooled genomic sequencing
data. Clonal evolution traces the accumulation of spon-
taneous mutations that lead to the development of novel
bacterial clones. Authors evaluated their algorithms on
simulated data and show that their method is superior to
existing methods that do not take into account the se-
quential order of sequencing data.
Nguyen et al. [17] developed ManiNetCluster, a novel
computational tool that aligns and clusters gene co-
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expression networks that are associated with specific gen-
omic functions that are coordinated within a specific
phenotype. ManiNetCluster was successfully applied to
expression profiles across various model organisms as well
as the time series transcriptome data. Their publicly avail-
able tool provides a novel way for uncovering the coordin-
ation of gene functions across different conditions.
Ramakrishnan et al. [18] analyzed CLIP-seq data
from 60 human RNA-binding proteins (RBPs), which
are critical modulators of RNA metabolism in eu-
karyotes. Authors demonstrate that binding sites for
1/3 of the RBPs are conserved in > 50% of the verte-
brate species they evaluated. RBP binding sites were
also shown to be strongly conserved across primates,
and weakly conserved across birds and fishes. Au-
thors observed that binding sites in the 3′ genic re-
gions are more highly conserved across species than
binding sites in the 5′ genic regions. Gene set en-
richment analysis on highly conserved binding sites
of RBPs uncovered phenotypes associated with mul-
tiple development aberrations.
Liu et al. [19] report on a new fragment length bias
present in genome-wide chromatin interactions mea-
sured by genome architecture mapping (GAM) tech-
niques. To account for this bias, authors propose
normGAM, an R package that accounts for this new
bias, in addition to other existing biases including win-
dow detection frequency, mappability, and GC content
through the application of 5 different normalization
methods. Authors compare these normalization methods
and their ability to account the different biases, and ob-
serve that normalized GAM data are more strongly asso-
ciated with experimental validation through fluorescence
in situ hybridization experiments.
Westphal et al. [20] developed a Bayesian framework
that robustly identifies matching samples based on mul-
tiple types of next generation sequencing data, including
RNA-seq and MethylCap-seq. Such matching is critical,
given the accidental occurrence of sample swaps that
can occur in large scale omics studies. Authors demon-
strate the ability of reliably identifying samples using ~
20 million reads of RNA-seq data. They also report a re-
duced ability to identify samples as the sample quality
and read coverage degrade.
Lastly, Wang et al. [21] tackle the issue of accurately
predicting a patient’s genetic admixture by developing
a computational pipeline to determine an ancestry in-
formative marker (AIM) panel. Using ~ 1 million ex-
onic single nucleotide polymorphisms from the 1000
Genomes Project, the authors applied an In-statistic to
identify the SNPs that discriminated 3 continental
populations (African, European, and East Asian). They
compared the discriminatory ability of their AIM
panel in training and clinical datasets, and obtained
superior results to those obtained by other published
AIM panels.
Conference organization
The success of the 2019 ICIBM conference would not
have been possible without the dedication of the general
chair and members of the steering committee, program
committee, publication committee, workshop/tutorial
committee, publicity committee, award committee,
trainee committee, local organization committee and in-
dustry/sponsorship committee.
Our hosts and sponsors include The Ohio State
University Department of Biomedical Informatics,
National Science Foundation, The University of Texas
Health Science Center at Houston (UTHealth), BGI,
Global Genomics Services, Macrogen, and Karger.
General Chair - Lang Li, The Ohio State University,
Columbus OH, USA.
Steering Committee - Zhongming Zhao, Co-Chair,
The University of Texas Health Science Center at Houston,
USA; Kai Wang, Co-Chair, Children’s Hospital of
Philadelphia, USA; Yidong Chen, The University of
Texas Health Science Center at San Antonio, USA;
Kun Huang, Indiana University; Yi Xing, Children’s
Hospital of Philadelphia; Xiaohua Tony Hu, Drexel
University, USA; Elmer Bernstam, The University of
Texas Health Science Center at Houston.
Program Committee - Drs. Ewy Mathé, Co-Chair, The
Ohio State University, Columbus OH, USA; Chi
Zhang, Co-Chair, Indiana University, USA; Mehmet
M. Dalkilic, Indiana University ; Sha Cao, Indiana
University School of Medicine; Xia Ning, The Ohio
State University; Yan Zhang, The Ohio State Univer-
sity; Yan Guo, University of New Mexico; Qingguo
Wang, Memorial Sloan Kettering Cancer Center;
Zhongming Zhao, University of Texas Health Science
Center at Houston; Yan Guo, Vanderbilt University;
Matthew Hayes, Xavier University of Louisiana; Lei
Xie, City University of New York; Ying-Wooi Wan,
Baylor College of Medicine; Shantao Li, Stanford
University; Ping Zhang, The Ohio State University;
Lijun Cheng, Indiana University Bloomington; Qin
Ma, The Ohio State University; Yu Xue, Department
of Biomedical Engineering, College of Life Science
and Technology, Huazhong University of Science
and Technology, Wuhan, Hubei 430074, China; Yon-
ghui Wu, University of Florida; Sarath Janga, Indiana
University - Purdue University Indianapolis; Nitish
Mishra, University of Nebraska Medical Center;
Xiaoli Zhang, The Ohio State University; Aimin Li,
Xi'an University of Technology; Xiaoming Liu, Uni-
versity of South Florida; Lianbo Yu, The Ohio State
University; Yin Liu, University of Texas Health Sci-
ence Center at Houston; Tabrez Anwar Shamim
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Mohammad, Greehey Children's Cancer Research In-
stitute (GCCRI), UTHSCSA; Lu Liu, North Dakota
State University; Zhi Han, Indiana University School
of Medicicne; Zhenqing Ye, Mayo Clinic; Tianbao Li,
UT health of San Antonio; Ewy Mathe, The Ohio
State University; Junbai Wang, Radium Hospital; Jian-
hua Ruan, UT at San Antonio; Hatice Gulcin Ozer,
OSU Department of Biomedical Informatics; Junfeng
Xia, Institute of Physical Science and Information
Technology, Anhui University; Kun Huang, Indiana
University School of Medicine; Zhandong Liu, Baylor
College of Medicine; Lang Li, The Ohio State Univer-
sity; Shaojie Zhang, University of Central Florida; Han
Zhang, Nankai University; Tao Li, Nankai University;
Li Liao, University of Delaware; Yidong Chen, UT
Health Science Center at San Antonio; Jiayin Wang,
Xi'an Jiaotong University; Jingwen Yan, Indiana Uni-
versity - Purdue University Indianapolis; Jun Wan, In-
diana University School of Medicine; Yunyun Zhou,
University of Mississippi Medical Center; Guy Brock,
The Ohio State University; Youping Deng, UNIVER-
SITY OF HAWAII; Qiwei Li, Rice University; Chao-
chun Wei, Shanghai Jiao Tong University; Yang
Huang, Kaiser Permanente; Mirjana Maletic-Savatic,
Baylor College of Medicine; Peilin Jia, UTHealth; Jun
Kong, Emory University; Fuhai Li, The Methodist
Hospital, Weill Medical College of Cornell University;
Kai Wang, Children’s Hospital of Philadelphia; Jianlin
Cheng, University of Missouri Columbia; Chi Zhang,
Indiana University, School of Medicine; Zhi-Liang Ji,
Xiamen University; Manabu Torii, Kaiser Permanente;
Xiaofeng Song, Nanjing University of Aeronautics and
Astronautics; Min Zhao, University of the sunshine
coast; Yufeng Wang, University of Texas at San Anto-
nio; Abolfazl Doostparast, University of California,
Santa Barbara; Weichun Huang, NIH/NIEHS; Jim
Zheng, School of Biomedical Informatics, U Texas
Health Science Houston; Hua Xu, The University of
Texas School of Biomedical Informatics at Houston;
Yongsheng Bai, Indiana State University; Kai Wang,
Children’s Hospital of Philadelphia..
Publication Committee - Yan Guo, Co-Chair, University
of New Mexico; Xia Ning, Co-Chair, The Ohio State
University, Columbus OH, USA.
Workshop/Tutorial Committee - Michael Wagner, Co-
Chair, Cincinnati Children’s Hospital Medical Center,
USA; Jin Chen, Co-Chair, University of Kentucky, USA.
Publicity Committee - Maciej Pietrzak, Co-Chair, The
Ohio State University, Columbus OH, USA; Licong Cui,
Co-Chair, University of Kentucky, USA.
Award Committee - Long Lu, Co-Chair, Cincinnati
Children’s Hospital Center; Qiang (Shawn) Cheng, Co-
Chair, University of Kentucky; Qin Ma, The Ohio State
University, Columbus OH.
Trainee Committee - Tara Eicher, Co-Chair, The Ohio
State University, Columbus OH, USA; Astrid Manuel,
Co-Chair, The University of Texas Health Science
Center at Houston, USA.
Local Organization Committee - Shasha Bai, Co-Chair,
The Ohio State University, Columbus OH, USA; Lai
Wei, Co-Chair, The Ohio State University, Columbus
OH, USA.
Industry/Sponsorship Committee - Shiqiang Tao, Co-
Chair, University of Kentucky.
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